Longitudinal tracking and accumulation of polymeric nanoparticles in the context of cancer has largely occurred through identification of a fluorescent cargo. In this study, we created a dual extracellular acidic pH targeted polypyrrole-based hollow nanoparticle as a theranostic (maintain both therapeutic and diagnostic capabilities) agent for improved detection and treatment of ovarian cancer. Polypyrrole-hollow nanospheres (PPy-CS)
INTRODUCTION
In the United States, ovarian cancer is the fifth leading cause of cancer-related deaths among women. Although only affecting approximately 1 out every 75 women, the 5-year survival rate is only approximately 17%. The reason for this rather low survival rate is due to the lack of earlier detection of ovarian cancer. Most women who are diagnosed with ovarian cancer are being diagnosed in later stages (III and IV) rather than the earlier stages (I and II), where treatment is much more beneficial and effective. The current imaging modalities utilized are those such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). The lack of earlier detection stems from the inability for most imaging modalities to differentiate the presence of early stage ovarian tumors.
The current method of treatment consists of rounds of chemotherapy focused around the Enhanced Permeability Retention (EPR) effect. The EPR effect is the phenomenon in which molecules of certain molecules circulate through the body and eventually accumulate in tumor tissues much more so than in non-malignant areas.
However, there are limitations to the effectiveness of this method of treatment. Most chemotherapeutics are highly cytotoxic, compounds harmful to living cells, and display harmful effects to non-malignant areas. Due to the problems current methods have faced, alternative treatment options have been developed to provide patients with better care.
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The use of nanovehicles, targeting nanoparticles containing specified cargo, as a possible contrasting agent has shown great promise in substantially improving the detection and treatment of cancer [1, 2] . However, there still remain underlying problems and limitations to their effectiveness. The development of novel metallic-based nanovehicles utilizing receptor-targeting mechanisms has been extensively studied, due in part to the ability to track these metallic nanoparticles by means of nuclear imaging modalities and more recently optoacoustic imaging [3] . Unfortunately, the majority of metal components (Fe, Zn, Cu, Ti, Co, etc.) found in these nanoparticles exhibit some level of cytotoxicity. More specifically, the nanosized particles of these metal-oxides have recently shown to be toxic to some organisms [4] . Therefore, the use of polymer-based nanoparticles has garnered much attention as a possible theranostic tool in the treatment of cancer [5] . This interest is due to the low-cytotoxicity, controllable permeability, and surface functionality inherently found in polymer-based hollow nanospheres [6] [7] [8] .
However, polymer-based nanoparticles themselves have encountered obstacles which have resulted in its further development as well. Difficulties in tracking polymerbased nanoparticles result from a general requirement of additional contrast dyes, radiolabels, or other tracking moieties to determine in vivo biodistribution and accumulation. With this in mind, a traceable compound, pyrrole, was selected to provide an encapsulation coat for cargo. Uniquely, polypyrrole polymers display an inherent absorbing property in which the pyrrole absorbs at the higher level of the spectrum, approximately 980 nm [9] . This inherent emittance of signal, by the pyrrole nanoparticle, allows for enhanced levels of tracking of the nanocontrasting agent, while in vivo with the use of optoacoustic tomography. Nanocontrasting agents serve as vehicles which contain contrast agents, such as dyes, that allow for better detection by an imaging modality. This polypyrrole chitosan-coated hollow nanosphere (PPy-CS Hollow Nanosphere) is unique in the fact that it emits a photoacoustic signal without the aid of an additional NIR-dye cargo. From the research we have conducted, contemporary nanoparticles do not display any detectable absorbance properties which would allow for such enhanced detection. This nanoparticle, in unison with the emerging modality of optoacoustic imaging, can address many of the shortcomings of current diagnosis methods as well as enhance targeted drug delivery to tumor cells.
Currently, nuclear imaging is the foremost imaging modality used in terms of noninvasive in-situ imaging of biological tissues and materials. However, with the need for further improvement of image resolution and quality, optoacoustic imaging has emerged as a promising novel biomedical imaging modality [10, 11] . Unlike nuclear imaging, optoacoustic imaging does not solely utilize radio-labels and radioactive material [12] as a means to trace a contrasting agent, rather it emits light energy which then reflects off of the contrast agent and produces a sound wave which is then recorded by an ultrasonic transducer allowing for an ultrasound image with higher resolution [13] [14] [15] [16] .
Multispectral optoacoustic tomography (MSOT) combines the benefits of enhanced sensitivity found in optical imaging and the depth of detection that is usually associated with ultrasound [17] . The ability for detection without the need for application of radiation is a significant benefit due to the damaging side-effects associated with prolonged exposure to radiation [18, 19] . An advantage of MSOT imaging also includes its ability to compile molecular and functional information, with high spatial resolution, in real-time. Also, it is able to distinguish various contrasting agents already present within the tissue, e.g. hemoglobin [16, 18] . Due to optoacoustic imaging's ability to detect absorbing molecules at depth, it provides a means of detection for absorbing nanoparticles which would allow for determination of the overall accumulation and biodistribution in real time. In current mice models, this process occurs over a process of hours until the nanoparticles are able to completely reach the tumor microenvironment. The advantages of optoacoustic imaging capabilities provide essential features including less exposure to radiation, rendering of more in-depth imaging, and a lesser invasive procedure than that of current modalities. Therein lies the need for the further development of enhanced tumor targeting agents [20] [21] [22] [23] [24] .
In order for nanovehicles to be effective in the clinic, the nanovehicle must have: 1) increased tumor-specific accumulation and reduced off-target binding, and 2) increased signal/payload within tumors than compared to current diagnostic or therapeutic agents While additional biological barriers, e.g. poor vascularity [25] and presence of stroma [26] , associated with recalcitrant tumors present additional challenges for development of nanovehicles, these recalcitrant tumors also offer the potential for high clinical impact for theranostic agents. Tumor-environments display various hallmark features which include acidic extracellular pH [27] , increased levels of hypoxia [28] , presence of autoantibodies [29] etc. With this in mind, we exploited the presence of acidic pH in the extracellular matrix of tumor cells as a general feature that would not be present in non-malignant tissue. In the clinic, tumors have acidic pHe (6.4-6.8) compared to nonmalignant tissue (pHe 7.2-7.4) [30] ; however, this small difference in extracellular pH alters the function, metastatic potential, and survival of tumor cells. To exploit the acidic extracellular pH as a targeting strategy for our polypyrrole nanocontrasting agent, we utilized a V7 pHLIP (pH Low Insertion Peptide), which changes conformation in response to its environment. In neutral pHe (7.2-7.4), it maintains a globular form and transforms to a transmembrane alpha-helix at acidic pHe conditions (6.4-6.8), this then allows the conjugated particle to insert and anchor into tumor cells [31] [32] [33] .
pHLIPs are a specialized group of peptides derived from the bacteriorhodopsin C helix which maintain water solubility and semi-hydrophobicity. In neutral or higher pH levels, the pHLIP is monomeric, remains non-reactive, and retains an unstructured or globular form. However, when placed in an acidic environment, it leads to the protonation of negatively charged residues on the helical segment and results in a shift in equilibrium, ultimately forming the alpha-helix structure [31] . Multiple studies have been successfully conducted with the use of pHLIPS as an additional modifier to existing polymer-based nanoparticles for pH-sensitive in vivo targeting for delivery as well as imaging [34, 35] .
Recently, several types of ligand based probes and inorganic nanoparticles have been detected using optoacoustic imaging for improved cancer detection in glioma, breast, and pancreatic cancers [36] . Near-infrared(NIR) fluorescent dyes conjugated to tumor targeted ligands and gold nanomaterials (including nanorods, and gold composite nanostructures) are likely the most-widely explored exogenous contrast agents for optoacoustic imaging. A number of other inorganic nanomaterials, including gold and silver nanoparticles, have also demonstrated tumor specificity [6, 37] , albeit often in subcutaneous tumors. However, the majority of inorganic nanoparticles have high uptake in the MPS system and may remain in the subject for long periods of time without the potential of degradation. This is a serious problem for the development of nanocontrasting agents for clinical use as patients often will receive multiple doses over time to determine tumor response, progression, and potentially even local metastasis. Therefore, the use of NIR absorbing organic nanoparticles offers a substantial improvement as nanocontrasting agents detectable by optoacoustic imaging.
In this study, I synthesized, modified, and evaluated an acidic extracellular pHtargeting polypyrrole chitosan-coated hollow nanosphere as a tumor targeting nanocontrasting agent detectable by multispectral optoacoustic tomography [38, 39] . With the addition of the V7 ligand to the PPy-CS, the nanoparticle displayed enhanced targeting capabilities in vitro. To the extent of my knowledge, this is the first
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recorded tracking of a polymer-based nanoparticle through optoacoustic imaging in any ovarian cancer cell line, without the use of an additional contrasting agent. This nanoparticle is unique in the fact that the polypyrrole-coating provides an enhanced spectrum of detection through its inherent absorbance in the infrared region. The incorporation of this nanoparticle and fluorescent dye has proved to be a successful contrast agent and displays great promise for possible future use as a nanovehicle for chemotherapeutics.
RESULTS AND DISCUSSION

Particle Synthesis and Characterization
The schematic seen in Figure 1 displays the experimental method which was used to synthesize the PPy-CS. From transmission electron microscopy (TEM) analysis ( Figure   1B ), we were able to confirm the successful removal of the AgCl cores as well as the desired relatively small-size of 43.56 ± 9 nm in diameter with a pore-size of 15 ± 6 nm (This size is approximately equivalent to the eye-lash of Abraham Lincoln on the penny).
Nanoparticles with a size greater than 100 nm tend to be too large and would eventually be filtered out by macrophage found in the liver or kidneys [40] . Therefore, particle size control played a crucial part during the synthesis of these particles. Additionally, particle size was confirmed with the use of dynamic light scattering (DLS) [41] . Figure 2 displays the DLS measurement of the PPy-CS maintaining a particle size of 51.39 nm. This measurement was slightly larger than the desired range of less than 50 nm; however, it remained consistent with the readings from the TEM images. This desired size was obtained through a series of dialysis in ammonium hydroxide and modified measurements of the initial substrates to form the silver-chloride core. Zeta potential was incorporated to measure the change in voltage exhibited by the nanosphere [42] . Zeta potential is utilized in determining the potential difference between a solid surface of a particle and its conducting solvent. This technique was used to help determine the expansion of the chitosan-coat in the presence of acidic pH and to ensure encapsulation in the presence of more neutral pH. The zeta potential of the nanospheres in various pH displayed a difference of -12.4 to -9.6 ( Figure 3 ). An increase in voltage was seen as the corresponding pH decreased [43, 44] . As pH decreased, the attraction/stability between the pyrrole-coating and chitosan increased and resulted in enhanced binding with regards to pH-specificity. These results confirmed the formation of the nanosphere with a functional chitosan-coat. The absorbance properties displayed by the PPy-CS, alone, allowed for detection using MSOT without the aid of a dye or any other indicator. This inherent absorbance signal provides a significant advantage to the further development of tumor-targeting nanocontrasting agents. To the best of our knowledge, we believe this is the first study that depicts the tracking ability of a polymer particle without the aid of an additional contrasting agent by means of optoacoustic imaging. With the aid of the MSOT system, we were able to determine that the synthesized nanosphere displayed its own unique absorbance signal which was distinguishable from the IR-780 dye (Figure 4 ). The pyrrole, alone, emitted a signal greater than 800 nm and extended onward, while the PPy-CS hollow nanospheres emitted a peak at 710 nm ( Figure 5 ). The nanoparticle, containing IR-780 dye, was introduced to both cell lines and placed on a rocker in a non-CO2 incubator to allow for distribution of the particle throughout the well. 
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Cellular uptake of PPy-CS
To further determine the pH specificity of the PPy-CS, fluorescence microscopy was performed to verify whether or not the PPy-CS were truly being anchored into the tumor cells [45] . Propidium iodide was utilized as the contrasting agent. Because Propidium iodide is not a cell permeable dye, it was encapsulated into the nanospheres in order to monitor the intracellular uptake and dye release in conjunction with acidic pHe. The fluorescence of red compared to green confirmed whether cellular uptake or accumulation on the surface was taking place.
Dye-Release Assessment of Cargo-Carrying Capability
PPy-CS loaded with IR-780 dye were evaluated for pH-specific dye release. The dye-conjugated nanoparticles were introduced into phosphate buffer saline (PBS) solutions of pH 6.6, 6.9, or 7.4. The PPy-CS in PBS solution of pH 6.6 were found to have released ~1.7 times greater the amount of IR-780 dye compared to those in PBS solution of pH 6.9 and 7.4 ( Figure 8 ). It was determined that the level of absorbance directly correlated with the amount of IR-780 dye that had been released from the PPy-CS [46] .
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This contrast in dye release illustrates the preferential release of cargo displayed by the PPy-CS. From these dye-release kinetics, it can be inferred that introduction of the nanospheres in vivo will result in targeted release of cargo to the tumor-region and limited off-targeting to non-malignant tissue. In a clinical setting, the nanovehcles, containing the infrared dye, is detected with a handheld scanner and the image is then seen on the optoacoustic system. This provides a less-invasive and more accessible method of imaging than compared to current methods. The pyrrole-coating provided a flexible structure which allowed for the nanosphere to better conform to its surroundings [47] . The PPy-CS were better-equipped to adapt to the change from neutral pH to more acidic pH without fracturing the overall integrity of the structure and pre-maturely releasing its cargo. The chitosan-coating expanded, in the presence of acidic pH, and released the dye. However, in the presence of neutral pH, the chitosan-coating would remain intact and continue to encapsulate the dye. This specified targeting and specified release helped to prevent off-targeting. The PPy-CS, carrying dye, required a rate of release that was not immediate and random, but discharged at a rate in which a majority of the dye was gradually released in the tumor-region.
CONCLUSION
In this study, pyrrole exhibited inherent absorbance properties which allowed it to be detected without the aid of a contrasting dye. This distinction would allow for a more precise tracking of the targeted nanosphere in vivo. With pyrrole serving as the principal encapsulating vehicle, a hollow nanosphere with a dual pH-specific mechanism was developed using a silver-chloride core template with pyrrole and chitosan-coating. It was then conjugated with a specifically designed pH-specific reactive ligand to allow for tumor- Using various imaging modalities, we further evaluated the biodistribution and tracking of the PPy-CS and established that the nanospheres exhibited amplified signaling and pH specificity. This unique inherent absorbance displayed by the PPy-CS allowed for enhanced detection of the nanosphere by the imaging system. The inherent absorbance provided an individual spectrum which allowed for a distinction between the actual nanoparticle and the location of the IR-780 dye. Being able to distinguish the location of the separate components allowed for a more accurate interpretation of the effectiveness that the nanoparticle would display in locating the desired tumor-region.
In future studies, the PPy-CS will be functionalized to serve as nanocarriers for chemotherapeutics due to its unique tracking capabilities in photoacoustic imaging. Additional modifications will be made to the nanoparticle to develop it as a radiosensitizer to allow for enhanced treatment in radiation therapy. The further elaboration of this study provides great potential toward the development of a theranostic agent for clinical applications. Fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) and the V7 ligand (Cisbio, Bedford, MA) were used as received.
Characterizations: The UV-vis absorption spectra were recorded with both MSOT and a Thermo-Scientific Model NanoDrop 2000 spectrophotometer. TEM images were obtained using a Tecnai-F20. Each TEM sample was prepared by dropping 50 µL of nanoparticle solution (in Milli-Q) on to copper-mesh grids (Electron Microscopy Science, Hatfield, PA) and they were then allowed to dry in room temperature overnight before imaging. For zeta-potential, the samples were measured by a Zetasizer Nano-ZS (Malvern Instruments Ltd.) at room temperature. Smoluchowski's equation was used to determine the electrophoretic mobility (µE) of the sample:
The ζ stands for the zeta-potential, ε the existing permittivity of the solvent, and η the viscosity of solvent. The same Zetasizer Nano-ZS (Malvern Instruments Ltd.) was used to measure size distribution for Dynamic Light Scattering (DLS).
Preparation of Materials: Stir bars, spatulas, and beakers were cleaned and thoroughly rinsed with DI water and Ethanol, and were then placed in autoclave. Materials were allowed to cool before any reactants were added. In Vitro Infrared Imaging to Determine pH-specificity: A2780 and ES-2 cells were placed in 6-well plates at a density of 500,000 cells per well. The 2 separate rows contained varying pH-media. One contained a pH of 6.6, whereas the other maintained a pH of 7.4. After 24 hrs of incubation at 37° C and non-CO2, 50 µL of V7-conjugated PPy-CS hollow nanosphere (22.85 µM) was introduced to two of the columns for the A2780 and the ES-2 cells. The last column served as a control group. The cell-plates were placed on a rocker in the non-CO2 incubator for 20 min; it was then placed on the Odyssey (LI-COR Biosciences) to determine if there was signaling present. Once signaling was detected, the cell-plates were washed with the corresponding phosphate buffer solution (PBS) and then placed back in to non-CO2 incubator for an additional 20 min. The need for placement in a non-CO2 environment stemmed from the desire to prevent sidereactions between the pH-specified phosphate buffer and the environmental carbondioxide. This process was repeated 3 times until optimal pH-specific signaling was achieved. Dosimetry analysis of IR-780 dye was conducted using Image-J software.
Optoacoustic Imaging of Tissue Phantoms: Tissue Phantoms (A mixture of agar and lipid used to mimic living tissue) provide an ideal model in allowing for comparable density and size found in mice. This model of imaging allows for an indicator of possible success in vivo. ES-2 cells were placed into 6-well plates for 24 hrs in DMEM media. After completion, the media were removed, pH-specific media were then applied and the cells were incubated for 4 hrs at 37°C in non-CO2. The PPy-CS hollow nanospheres (50 µL)
were then added to the wells and rocked in the incubator for an additional 2 hrs. Next, the cells underwent a series of 3 washes with specified PBS of pH 6.6 and 7.4 to each row. During tissue phantom imaging, two samples were used to determine which procedure, for the addition of APTES, provided the greatest difference in signal between pH of 7.4 and 6.6. Both particle samples resulted in a difference in the signal intensity. However, the addition of APTES before the conjugation of SMCC and V7 displayed a greater difference in signal intensity compared to the addition of APTES along with the initial PPy-CS hollow nanospheres. APTES (First) displayed a difference of approximately 7 times more intensity for pH 6.6 compared to 7.4. APTES (Later) displayed a difference of approximately 9.4 times more intensity for pH 6.6 compared to 7.4. Figure 8 : PPy-CS hollow nanospheres loaded with IR-780 dye were evaluated for pHspecific dye release. The dye-conjugated nanoparticles were introduced into phosphate buffer saline (PBS) solutions of pH 6.6, 6.9, or 7.4. The absorbance level of each solution was measured by UV-Vis spectroscopy over a 10 hour period. It was determined that the level of absorbance directly correlated with the amount of IR-780 dye that had been released from the PPy-CS hollow nanospheres. The PPy-CS hollow nanospheres in PBS solution of pH 6.6 were found to have
